Daptomycin

Product NDC
0143-9455
11-digit product format
001439455
Labeler code
0143
Product ID
0143-9455_34a28940-21e7-4056-9ab8-dfac30198662
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Daptomycin
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
Hikma Pharmaceuticals USA Inc.
Application
NDA209949
Marketing category
NDA
Marketing start
2026-02-25
Substance
DAPTOMYCIN
Active strength
350 mg/7mL
Pharmacologic classes
Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N209949-001DAPTOMYCINDAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-204b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-2074a2ff9319b5…
2022-03-09 01:35 UTC2022-03N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-2087673890dc5c…
2021-03-12 10:30 UTC2021-03N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-205aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-208869cabd3fbd…
2020-11-12 02:37 UTC2020-11N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-20c0c555d07b60…
2019-12-14 00:12 UTC2019-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-203f01610625f2…
2019-09-15 20:21 UTC2019-09N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-20b00525d2431f…
2019-07-19 19:46 UTC2019-07N209949-001DAPTOMYCIN350MG/VIALPOWDER / IV (INFUSION)RLD, RS2017-10-20ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-206a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-201c564ffb4f44…
2023-12-20 04:57 UTC2023-12N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-209b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-203f0d92c62455…
2023-05-13 08:27 UTC2023-05N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20053a50430f4f…
2023-01-26 05:58 UTC2023-01N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-203bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-203a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N209949-001DAPTOMYCIN350MG/VIALPOWDER / INTRAVENOUSRLD, RS2017-10-20cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Daptomycin
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DAPTOMYCIN350 mg/7mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
NWQ5N31VKKInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1996246Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
23f39005-3008-4ab1-918d-b8acb001554eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
45ca3ac7-6ee8-4e99-92a6-dc0b401e151aProduct name120250724
223d8260-7a4e-4ebd-9635-845422d6a8adProduct name920240909
ca803a62-3799-476f-bbc6-024f77cb0320Product name420240207
cad85d83-8fb9-49f8-a5a6-a399af412964Product name120230922
8e59a5ed-f224-4156-b534-1ae4d0b6dfd7Product name120230721
ea2c89ab-e8f8-425f-9693-c923fa1e1703Product name120220929

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0143-9455-01Daptomycin7 mL in 1 VIAL, SINGLE-USEINJECTION, POWDER, LYOPHILIZED,73
0143-9455-01Daptomycin1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0143-9455-01EA - Each0143-9455376958be-761a-4be5-ae86-ba83b6d29ca612026-03-17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DaptomycinDAPTOMYCINHikma Pharmaceuticals USA Inc.23f39005-3008-4ab1-918d-b8acb001554e2026-03-23Warnings, Adverse reactionsExact identifier
application applno (NDA): 209949
application number: NDA209949
ndc (product): 0143-9455
DaptomycinDAPTOMYCINXellia Pharmaceuticals USA LLC97c47c18-985d-4373-88f7-a86ec591ea442024-04-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 209949
application number: NDA209949
DaptomycinDAPTOMYCINCivica, Inc.bcacf746-a3ee-48b5-bfbe-6a2b548ad24c2024-04-05Warnings, Adverse reactionsExact identifier
application applno (NDA): 209949
application number: NDA209949

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1996246DAPTOmycin 350 MG InjectionPSN23f39005-3008-4ab1-918d-b8acb001554e3
1996246daptomycin 350 MG InjectionSCD23f39005-3008-4ab1-918d-b8acb001554e3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0143-9455-01001439455011 VIAL, SINGLE-USE in 1 CARTON (0143-9455-01) / 7 mL in 1 VIAL, SINGLE-USE2026-02-25NoNoCurrent